Cognigenics
cognigenics.ioCognigenics develops innovative RNA-based gene therapies targeting memory loss, cognitive decline, and anxiety associated with mild cognitive impairment and other neurocognitive and neuropsychiatric disorders. Our intranasal delivery platform targets neuronal receptors in the brain involved in CNS disorders, including anxiety and mild cognitive impairment.
Something looks off?Open jobs at Cognigenics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.